Megahed on the Effects of NGS on First-Line Treatment Decisions in NSCLC
Ahmed Megahed, MBBCh, discusses the rationale for investigating the effects of next-generation sequencing on first-line treatment decisions for patients with stage IV non–small cell lung cancer.